Tuesday, October 19, 2021

10:00 a.m. to 5:00 p.m. Eastern Daylight Time

Chair: O. John Semmes, PhD, Eastern Virginia Medical School

Co-Chair: Martin Sanda, MD, Emory University School of Medicine

NCI Program Directors:   Jacob Kagan, MSc, PhD, and Richard Mazurchuk, PhD, National Cancer Institute

Agenda

10:00 a.m. – 10:05 a.m.                         Welcome  

• John Semmes, PhD, East Virginia Medical School
• Martin Sanda, MD, Emory University School of Medicine

10:05 a.m. – 10:10 a.m.                         NCI Updates

• Jacob Kagan, MSc, PhD National Cancer Institute
• Richard Mazurchuk, PhD, National Cancer Institute

10:10 a.m. – 10:25 a.m.                         Report from the Advocates  

              Merel Grey Nissenberg, Esq., President, California Prostate Cancer Coalition

10:25 a.m. – 11:15 a.m.                         Team Projects and Projects (Supported with CORE Funds)

• What was accomplished and what remains to be done
• Feasibility of completion
• Lessons learned
• Recommendations for improvements

10:25 a.m. – 10:45 a.m.                      P-MRI Study Update

                                                                        John T. Wei, MD, University of Michigan

10:45 a.m. – 10:50 a.m.                      Q&A

10:50 a.m. – 11:10 a.m.                      The Prostate Tissue Upgrading Study

• Phase 1: Robin Leach, PhD, The University of Texas Health Science Center San Antonio
• Phase 2: Paul Boutros, PhD, MBA, Cancer Data Science, University of California, Los Angeles

11:10 a.m. – 11:15 a.m.                      Q&A  

Team Projects and Projects (Supported with CORE Funds Continued

11:15 a.m.  – 11:25 a.m.                        Break

11:25 a.m. – 2:50 p.m.                            Updates on GU Collaborative Group’s Studies

11:25 a.m. – 11:45 p.m.                      Title TBD

                                                                    Arul Chinnaiyan MD, PhD, University of Michigan

11:45 a.m. – 11:50 a.m.                      Q&A

11:50 p.m. – 12:10 p.m.                      Glycoprotein marker panels for aggressive prostate cancer detection

                                                                    Hui Zhang, PhD, Johns Hopkins University School of Medicine

12:10 p.m. – 12:15 p.m.                      Q&A

12:15 p.m. – 12:35 p.m.                      Proteomics Approaches to Detect Aggressive Prostate Cancers

                                                                    Thomas Kislinger, MSc, PhD, University of Toronto

12:35 p.m. – 12:40 p.m.                      Q&A

12:40 p.m. – 1:00 p.m.                        Title TBD

                                                                    Martin Sanda, MD, Emory University

1:00 p.m. – 1:05 p.m.                           Q&A

1:05 p.m. – 1:35 p.m.                              Lunch Break

1:35 p.m. – 1:55 p.m.                           Development of a panel of biomarkers for aggressive prostate cancer

                                                                    Daniel W. Chan, PhD, Johns Hopkins University

1:55 p.m. – 2:00 p.m.                           Q&A

2:00 p.m. – 2:20 p.m.                           Towards early prediction of prostate cancer progression applying advanced mass spectrometry technologies

                                                                    Tao Liu PhD Pacific Northwest National Laboratory

2:20 p.m. – 2:25 p.m.                           Q&A

2:25 p.m. – 2:45 p.m.                           CPDR-EDRN BRL: Dynamic Progress of Collaborative Biomarker Projects

                                                                                                                                            Gyorgy Petrovics, PhD, Center for Prostate Disease Research (CPDR)

2:45 p.m. – 2:50 p.m.                           Q&A

1dkdkdk

2:50 p.m. – 3:00 p.m.                              Break

3:00 p.m. – 4:00 p.m.                              Discussion of Prostate Cancer Clinical Utility Study

Moderator: Martin Sanda, MD Emory University

                                                                        Discussants:

• Yingye Zheng, PhD, Fred Hutchinson Cancer Research Center
• Martin Sanda, MD, Emory University
• Alan W. Partin, MD, PhD, Johns Hopkins University
• Jeffrey Tosoian, MD, MPH, Vanderbilt University

4:00 p.m. – 5:00 p.m.                              Summary and Open Discussion of the Current and Future Directions of the GU Collaborative Group

1. John Semmes, PhD, East Virginia Medical School

5:00 p.m.                                                     Adjourn for the Day